Respiratory Medicine

Article	Citations
Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae	242
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians	209
Pulmonary function and health-related quality of life after COVID-19 pneumonia	125
Levels of resilience, anxiety and depression in nurses working in respiratory clinical areas during the COVID pandemic	95
The role of oral microbiome in respiratory health and diseases	84
Smoking and COVID-19: What we know so far	82
Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae	81
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudin	72
COVID-19: Why does disease severity vary among individuals?	67
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge	58
Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study	49
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study	49
Idiopathic pulmonary hemosiderosis: A state of the art review	49
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state	47
Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors	46
Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience	46
Managing malnutrition in COPD: A review	46
Risk factors and associated outcomes of hospital readmission in COPD: A systematic review	46
Tobacco use as a well-recognized cause of severe COVID-19 manifestations	45
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity	43
Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation	42
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study	40
Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis	39
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study	38
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy	38

The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature	37
Survival in COPD patients treated with bronchoscopic lung volume reduction	37
Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options	36
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge	35
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure	34
Smoking and risk of COVID-19 hospitalization	34
Guidance on nebulization during the current COVID-19 pandemic	34
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection	34
Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications	34
Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan	34
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19	33
The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study	33
Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients	33
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases	32
Controversy surrounding the Sputnik V vaccine	31
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype	31
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients	31
Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up	31
Aspiration pneumonia: A renewed perspective and practical approach	30
The use of cough peak flow in the assessment of respiratory function in clinical practice- A narrative literature review	29
Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease	29
Severity does not impact on exercise capacity in COVID-19 survivors	29
Electrical impedance tomography: A compass for the safe route to optimal PEEP	28
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation	28
Asthma patients' and physicians’ perspectives on the burden and management of asthma	26
Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study	26
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale	26
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2	26
Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases	25
A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia	25
Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity	24
Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital	24
A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma	24
Diagnosis of tuberculous pleural effusions: A review	24
Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies	24
Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic	23
Factors associated with anxiety and depression among patients with Covid-19	23
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry	22
Depressive and anxiety symptoms in patients with COPD: A network analysis	22
High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients	21
Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis	21
Decreased quality of life and spirometric alterations even after mild-moderate COVID-19	21
Prevalence and features of IOS-defined small airway disease across asthma severities	21
Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study	21
Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19	21
Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review	21
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity	21
Large underreporting of COPD as cause of death-results from a population-based cohort study	21
Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity	20
Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A scoping review	20

Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypoxemia	20
Current perspectives on the immunopathogenesis of sarcoidosis	19
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy	19
Endothelial function provides early prognostic information in patients with COVID-19: A cohort study	19
Effects of surgical and cloth facemasks during a submaximal exercise test in healthy adults	19
Respiratory care for the critical patients with 2019 novel coronavirus	19
Paediatric long term continuous positive airway pressure and noninvasive ventilation in France: A cross-sectional study	19
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study	19
Mortality and readmission in the year following hospitalization for pneumonia among US adults	19
Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study	19
Reduced pulmonary function, low-grade inflammation and increased risk of total and cardiovascular mortality in a general adult population: Prospective results from the Moli-sani study	18
The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress	18
Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD	18
Pulmonary manifestations in VEXAS syndrome	18
Update on the diagnosis and management of malignant pleural effusions	18
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry	18
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients	17
The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis	17
COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort	17
Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance	17
Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease	17
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria	16
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort	16
Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial	16
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study	16
Clusters of comorbidities in idiopathic pulmonary fibrosis	16
Pleuroparenchymal fibroelastosis: Clinical, radiological and histopathological features	16
Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit	16
The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control	16
Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study	16
Associations of asthma self-management and mental health in adolescents: A scoping review	15
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry	15
Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome	15
Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study	15
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases	15
Clinical and biological factors associated with irreversible airway obstruction in adult asthma	15
Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients’ data using machine learning - Based on the ARCTIC study	15
Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study	15
In-line treatments and clinical initiatives to fight against COVID-19 outbreak	14
Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population	14
Asthma in COVID-19 patients: An extra chain fitting around the neck?	14
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation	14
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits	14
Covid-19 and in situ pulmonary artery thrombosis	14
The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review	14
Immediate physiological effects of acute electronic cigarette use in humans: A systematic review and meta-analysis	14
Urinary volatile organic compound metabolites and reduced lung function in U.S. adults	14
The role of lung macrophages in chronic obstructive pulmonary disease	14
Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease	14
Suggestions for lung function testing in the context of COVID-19	14
COPD is a risk factor for COVID-19, but does not confer increased severity of the disease	14
Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis	14
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy	14
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover	14
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma	14
Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index	14
Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis	14
Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis	13
Multidimensional indices in the assessment of chronic obstructive pulmonary disease	13
Bronchiectasis and inhaled tobramycin: A literature review	13
Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry	13
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial	13
Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany	13
Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study	13
Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature	13
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment	13
Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial	13
Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension	13
Differences in disease presentation between men and women with sarcoidosis: A cohort study	13
Predictive value of chest CT scoring in COVID-19 patients in Wuhan, China: A retrospective cohort study	13
Macklin effect on baseline chest CT scan accurately predicts barotrauma in COVID-19 patients	13
Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation	13
Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis	13
Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program	12
Optimizing the management of complicated pleural effusion: From intrapleural agents to surgery	12
Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases	12
Risk of incident dementia and cognitive impairment in patients with chronic obstructive pulmonary disease (COPD): A large UK population-based study	12
HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis	12
Association of obesity-related inflammatory pathways with lung function and exercise capacity	12
Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease	12

Digital spacer data driven COPD inhaler adherence education: The OUTERSPACE proof-of-concept study	12
Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study	12
Non-invasive ventilation improves exercise tolerance and peripheral vascular function after high-intensity exercise in COPD-HF patients	12
Clinical, radiological, and pathological evaluation of “NSIP with OP overlap” pattern compared with NSIP in patients with idiopathic interstitial pneumonias	12
The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension	12
Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis	12
SARS-CoV-2 infection in alpha1-antitrypsin deficiency	11
Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience	11
Is the diagnostic yield of mediastinal lymph node cryobiopsy (cryoEBUS) better for diagnosing mediastinal node involvement compared to endobronchial ultrasound-guided transbronchial needle aspiration	11
High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis	11
The relationship between lung disease severity and the sputum proteome in cystic fibrosis	11
High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: A cohort study	11
Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation	11
Pneumothorax and barotrauma in invasively ventilated patients with COVID-19	11
Association of baseline diaphragm, rectus femoris and vastus intermedius muscle thickness with weaning from mechanical ventilation	11
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	11
Long COVID outcomes in an asthmatic cohort and its implications for asthma control	11
A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm	11
Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors	11
Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial	11
Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease	10
The association between carotid-femoral pulse-wave velocity and lung function in the Swedish CArdioPulmonary bioImage study (SCAPIS) cohort	10
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic	10
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)	10
Factors associated with “Frequent Exacerbator” phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry	10
Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: A 21-year longitudinal cohort study	10
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?	10
The role of FeNO in stable COPD patients with eosinophilic airway inflammation	10
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma	10
Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model	10
Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure	10
Interactions between microbiome and underlying mechanisms in asthma	10
Allergen immunotherapy for allergic asthma: The future seems bright	10
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study	10
Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease	10
Longitudinal validity and prognostic significance of the St George's Respiratory Questionnaire in Mycobacterium avium complex pulmonary disease	10
Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011–2014	10
Nasal and systemic inflammation in Chronic Obstructive Pulmonary Disease (COPD)	10
Panlobular emphysema is associated with COPD disease severity: A study of emphysema subtype by computed tomography	10
Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILD	10
Randomized controlled trial of community-based, post-rehabilitation exercise in COPD	10
Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population	10
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety	10
SMART for the treatment of asthma: A network meta-analysis of real-world evidence	10
The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma	10
High-flow nasal oxygen (HFNO) for patients with Covid-19 outside intensive care units	9
Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD tri	9
Serum C-reactive protein-to-albumin ratio is a potential risk indicator for pneumonia: Findings from a prospective cohort study	9
Clinical significance of minor salivary gland biopsy in patients with idiopathic interstitial pneumonia	9
Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications	9
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study	9
Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China	9
A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease	9
Benefits of pulmonary rehabilitation in COPD patients with mild cognitive impairment – A pilot study	9
Refining diagnostic criteria for paediatric bronchiectasis using low-dose CT scan	9
Investigating the diagnostic utility of high-resolution oesophageal manometry in patients with refractory respiratory symptoms	9
Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection	9
Early Initiation of non-invasive ventilation at home improves survival and reduces healthcare costs in COPD patients with chronic hypercapnic respiratory failure: A retrospective cohort study	9
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research	9
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience	9
Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany	9
Mouthpiece ventilation in neuromuscular disorders: Narrative review of technical issues important for clinical success	9
Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia	9
Sedentary time in people with obstructive airway diseases	9
Clinical outcomes of transbronchial cryobiopsy using a 1.1-mm diameter cryoprobe for peripheral lung lesions - A prospective pilot study	9
Predictive factors for success of awake proning in hypoxemic respiratory failure secondary to COVID-19: A retrospective cohort study	9
Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy – The population-based DISCOVERY study	9
Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation	9
Clinical features of acute exacerbation in rheumatoid arthritis–associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis	9
Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers	9
Association between inhaler technique and confidence among hospitalized children with asthma	9
Long-term cognitive and psychiatric outcomes of acute respiratory distress syndrome managed with Extracorporeal Membrane Oxygenation	9
Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension	9
Factors associated with delayed viral shedding in COVID-19 infected patients: A retrospective small-scale study	9
Clinical use of Macklin-like radiological sign (Macklin effect): A systematic review	9
Renal disease in sarcoidosis patients in a German multicentric retrospective cohort study	8
Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study	8
Lesion characteristics affecting yield of electromagnetic navigational bronchoscopy	8
The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety	8
Assessment of a close respiratory follow-up schedule at 3 and 6 months after acute COVID-19 and its related investigations	8
Determining extent of COVID-19 pneumonia on CT based on biological variables	8
High-intensity interval training improves the outcomes of patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials	8
Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease	8
Inspiratory muscle activation during inspiratory muscle training in patients with COPD	8
Sarcoidosis associated pleural effusion: Clinical aspects	8
Lung ultrasound findings following COVID-19 hospitalization: A prospective longitudinal cohort study	8
Relationship between prior inhaled corticosteroid use and benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung funct	8
Clinical, radiologic, and pathologic features and outcomes of pulmonary transthyretin amyloidosis	8
The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship	8
The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors	8
Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study	8
TRICOP – A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD	8
Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatment	8
Outcomes of prednisone-tapering regimens for cardiac sarcoidosis: A retrospective analysis demonstrating a benefit of infliximab	8
Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases	8